4//SEC Filing
Nanda Nisha 4
Accession 0001567619-19-000104
CIK 0001581720other
Filed
Jan 1, 7:00 PM ET
Accepted
Jan 2, 5:08 PM ET
Size
5.4 KB
Accession
0001567619-19-000104
Insider Transaction Report
Form 4
Nanda Nisha
Chief Development Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2019-01-02+37,000→ 37,000 totalExercise: $139.77Exp: 2029-01-01→ Common Stock (37,000 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable as to 1/48th of the total number of shares on February 2, 2019, then an additional 1/48th vests on each monthly anniversary thereafter, until such time as the option is 100% vested, subject to the reporting person's continued service through each vesting date.
Documents
Issuer
Loxo Oncology, Inc.
CIK 0001581720
Entity typeother
Related Parties
1- filerCIK 0001762683
Filing Metadata
- Form type
- 4
- Filed
- Jan 1, 7:00 PM ET
- Accepted
- Jan 2, 5:08 PM ET
- Size
- 5.4 KB